The Use Of Daily Continuous Glucose Monitoring (Chmg) In Clinical Practice
Author(s) -
Narbaev Abduhamid Namazovich,
Togaeva Gulnora Siddiqovna,
Davranova Aziza Davranovna
Publication year - 2020
Publication title -
the american journal of medical sciences and pharmaceutical research
Language(s) - English
Resource type - Journals
ISSN - 2689-1026
DOI - 10.37547/tajmspr/volume02issue09-17
Subject(s) - medicine , diabetes mellitus , continuous glucose monitoring , disease , clinical practice , type 2 diabetes mellitus , pediatrics , type 1 diabetes , chronic disease , intensive care medicine , endocrinology , physical therapy
Type 1 diabetes mellitus is a disease in which the highest rates of premature mortality and early disability of patients are observed, which is caused by the onset of the disease at an early age, the instability of the course of type 1 diabetes and the threat of acute and chronic complications. The goals of type 1 diabetes mellitus treatment are its compensation, prevention of the risk of complications when normoglycemia is reached and stabilized.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom